Viewing Study NCT01025167


Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2026-02-25 @ 8:25 PM
Study NCT ID: NCT01025167
Status: COMPLETED
Last Update Posted: 2010-08-20
First Post: 2009-12-02
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Effect of a New Specific Enteral Formula Compared to a Standard Formula on the Tolerability of a Combined Radio- and Chemotherapy in Cancer Patients
Sponsor: Fresenius Kabi
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: N-SUP-09-DE
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: Dr. Steffen Benzing
Old Organization: Kabi Innovation Centre, Fresenius Kabi Deutschland GmbH

Collaborators